Regulatory › Drugs@FDA › History › NDA209210 Drugs@FDA application timeline
NDA209210 18 dated FDA-coded AP submissions from 2017-10-20 through 2025-05-28, connected to 17 source-defined action assignments and 39 official document links.
18 Dated AP submissions
17 Action assignments
39 Official documents
0 Exact enforcement reports
1 Reviewed profile mappings
Reporting boundary This history reports exact Drugs@FDA submission status dates, source-defined action labels, and official document metadata for applications already selected by PeptideScanner. FDA's AP code and action labels are source metadata; this page does not interpret approval scope, reproduce document text, establish safety or effectiveness, or provide medical guidance. Document links open FDA-hosted material; PeptideScanner does not copy or summarize their contents.
Reviewed identity mapping
Connected peptide profiles Newest first
Submission and document chronology 18 submissions 2025-05-28 · status AP
Supplement 25 FDA action labels Labeling-Package Insert
3 official documents 2024-11-01 · status AP
Supplement 24 FDA action labels Labeling-Package Insert
3 official documents 2024-03-06 · status AP
Supplement 23 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2024-03-12 · FDA document 77781 Label ↗ 2024-03-07 · FDA document 77748 2022-12-21 · status AP
Supplement 22 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2022-12-23 · FDA document 73011 Letter ↗ 2022-12-22 · FDA document 72998 2022-07-26 · status AP
Supplement 19 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2022-07-27 · FDA document 71645 Letter ↗ 2022-07-27 · FDA document 71640 2022-06-10 · status AP
Supplement 21 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2022-06-15 · FDA document 71320 Letter ↗ 2022-06-14 · FDA document 71303 2021-07-22 · status AP
Supplement 17 FDA action labels Efficacy-New Indication
2 official documents Letter ↗ 2021-07-26 · FDA document 68179 Label ↗ 2021-07-23 · FDA document 68165 2020-12-02 · status AP
Supplement 14 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2020-12-03 · FDA document 65493 Label ↗ 2020-12-02 · FDA document 65476 2020-02-28 · status AP
Supplement 11 FDA action labels Labeling-Package Insert
2 official documents Letter ↗ 2020-03-03 · FDA document 62016 Label ↗ 2020-03-02 · FDA document 62006 2019-07-25 · status AP
Supplement 8 FDA action labels Labeling-Package Insert
2 official documents Label ↗ 2019-07-30 · FDA document 59505 Letter ↗ 2019-07-26 · FDA document 59461 2019-07-25 · status AP
Supplement 7 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2019-07-30 · FDA document 59507 Letter ↗ 2019-07-26 · FDA document 59460 2019-07-25 · status AP
Supplement 6 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2019-07-30 · FDA document 59508 Letter ↗ 2019-07-26 · FDA document 59459 2019-07-25 · status AP
Supplement 5 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2019-07-30 · FDA document 59509 Letter ↗ 2019-07-26 · FDA document 59458 2019-07-25 · status AP
Supplement 4 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2019-07-30 · FDA document 59510 Letter ↗ 2019-07-26 · FDA document 59457 2019-07-25 · status AP
Supplement 3 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2019-07-30 · FDA document 59511 Letter ↗ 2019-07-26 · FDA document 59456 2019-07-25 · status AP
Supplement 2 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Label ↗ 2019-07-30 · FDA document 59512 Letter ↗ 2019-07-26 · FDA document 59455 2019-02-15 · status AP
Supplement 1 FDA action labels Efficacy-Labeling Change With Clinical Data
2 official documents Letter ↗ 2019-02-21 · FDA document 57724 Label ↗ 2019-02-20 · FDA document 57708 2017-10-20 · status AP
Original submission 1 No source action-type assignment was retained for this submission.
3 official documents Review ↗ 2018-10-10 · FDA document 55864 Letter ↗ 2017-11-27 · FDA document 50488 Label ↗ 2017-10-24 · FDA document 50156 Source archive dated 2026-08-24; observed 2026-08-24T21:23:49.000Z; reviewed 2026-08-24. Observation SHA-256: 6166fd223ef126a19e8ebfdaafe1fbf7c330a4cf7153cef00fb6c52c45ef757b.